{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:36:17Z","timestamp":1787790977395,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.mayocp.2020.10.042","type":"journal-article","created":{"date-parts":[[2021,5,2]],"date-time":"2021-05-02T16:12:38Z","timestamp":1619971958000},"page":"1510-1519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Using Reticulocyte Hemoglobin Equivalent as a Marker for Iron Deficiency and Responsiveness to Iron Therapy"],"prefix":"10.1016","volume":"96","author":[{"given":"Michael","family":"Auerbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Staffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8192-8713","authenticated-orcid":false,"given":"Carlo","family":"Brugnara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mayocp.2020.10.042_bib1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/10408363.2015.1038744","article-title":"Diagnosis of iron-deficient states","volume":"52","author":"Archer","year":"2015","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"5","key":"10.1016\/j.mayocp.2020.10.042_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1373\/clinchem.2012.182071","article-title":"Iron deficiency: what are the future trends in diagnostics and therapeutics?","volume":"59","author":"Brugnara","year":"2013","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.mayocp.2020.10.042_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MOH.0b013e32835f5933","article-title":"Red cell indices in classification and treatment of anemias: from M.M. Wintrobes's original 1934 classification to the third millennium","volume":"20","author":"Brugnara","year":"2013","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"10.1016\/j.mayocp.2020.10.042_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ajcp\/108.2.133","article-title":"Reticulocyte hemoglobin - An integrated parameter for evaluation of erythropoietic activity","volume":"108","author":"Brugnara","year":"1997","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.mayocp.2020.10.042_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0002-9343(94)90134-1","article-title":"Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response","volume":"96","author":"Rutherford","year":"1994","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2020.10.042_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000486968","article-title":"Positive iron balance in chronic kidney disease: how much is too much and how to tell?","volume":"47","author":"Wish","year":"2018","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.mayocp.2020.10.042_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/ajcp\/102.5.623","article-title":"Automated reticulocyte counting and measurement of reticulocyte cellular indexes - evaluation of the Miles-H\u22173-blood-analyzer","volume":"102","author":"Brugnara","year":"1994","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.mayocp.2020.10.042_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2257.2006.00812.x","article-title":"Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states","volume":"28","author":"Brugnara","year":"2006","journal-title":"Clin Lab Haematol"},{"issue":"10","key":"10.1016\/j.mayocp.2020.10.042_bib9","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1515\/CCLM.2010.292","article-title":"Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis","volume":"48","author":"Piva","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.mayocp.2020.10.042_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ajh.23110","article-title":"Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation","volume":"87","author":"Sun","year":"2012","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.mayocp.2020.10.042_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","article-title":"Anemia of inflammation","volume":"133","author":"Weiss","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.mayocp.2020.10.042_bib12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1182\/blood.V99.4.1489","article-title":"Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency","volume":"99","author":"Mast","year":"2002","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.mayocp.2020.10.042_bib13","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1001\/jama.281.23.2225","article-title":"Reticulocyte hemoglobin content to diagnose iron deficiency in children.[comment]","volume":"281","author":"Brugnara","year":"1999","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.mayocp.2020.10.042_bib14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.294.8.924","article-title":"Screening healthy infants for iron deficiency using reticulocyte hemoglobin content","volume":"294","author":"Ullrich","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mayocp.2020.10.042_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jadohealth.2004.09.011","article-title":"An algorithm using reticulocyte hemoglobin content (CHr) measurement in screening adolescents for iron deficiency","volume":"36","author":"Stoffman","year":"2005","journal-title":"J\u00a0Adolesc Health"},{"issue":"1","key":"10.1016\/j.mayocp.2020.10.042_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ki.1997.323","article-title":"Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients","volume":"52","author":"Fishbane","year":"1997","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.mayocp.2020.10.042_bib17","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/16.7.1416","article-title":"The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin","volume":"16","author":"Tessitore","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.mayocp.2020.10.042_bib18","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1515\/cclm-2016-0041","article-title":"Evaluation of the hypochromic erythrocyte and reticulocyte hemoglobin content provided by the Sysmex XE-5000 analyzer in diagnosis of iron deficiency erythropoiesis","volume":"54","author":"Buttarello","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"10.1016\/j.mayocp.2020.10.042_bib19","doi-asserted-by":"crossref","first-page":"e23225","DOI":"10.1002\/jcla.23225","article-title":"Diagnostic performance of reticulocyte hemoglobin equivalent in assessing the iron status","volume":"34","author":"Chinudomwong","year":"2020","journal-title":"J\u00a0Clin Lab Anal"},{"issue":"2","key":"10.1016\/j.mayocp.2020.10.042_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00365513.2019.1700549","article-title":"Reticulocyte hemoglobin and hypochromic erythrocytes in the study of erythropoiesis in patients with inflammatory bowel disease","volume":"80","author":"Urrechaga","year":"2020","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"10.1016\/j.mayocp.2020.10.042_bib21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12185-017-2212-6","article-title":"Reticulocyte hemoglobin equivalent as a potential marker for diagnosis of iron deficiency","volume":"106","author":"Toki","year":"2017","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.mayocp.2020.10.042_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1309\/AJCPCVZ5B0BOYJGN","article-title":"Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancer","volume":"142","author":"Peerschke","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.mayocp.2020.10.042_bib23","first-page":"219","article-title":"Stability of new erythrocyte and reticulocyte parameters in testing for anemia on the Sysmex XN 9000","volume":"49","author":"Schapkaitz","year":"2018","journal-title":"Lab Med"},{"issue":"4","key":"10.1016\/j.mayocp.2020.10.042_bib24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/ijlh.12496","article-title":"Percentage of hypochromic erythrocytes and reticulocyte hemoglobin equivalent predictors of response to intravenous iron in hemodialysis patients","volume":"38","author":"Urrechaga","year":"2016","journal-title":"Int J Lab Hematol"},{"issue":"9","key":"10.1016\/j.mayocp.2020.10.042_bib25","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.3324\/haematol.2014.106799","article-title":"Hematologic parameters predicting a response to oral iron therapy in chronic inflammation","volume":"99","author":"van Santen","year":"2014","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.mayocp.2020.10.042_bib26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood.2019004017","article-title":"How I treat cancer-associated anemia","volume":"136","author":"Gilreath","year":"2020","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.mayocp.2020.10.042_bib27","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ajh.22153","article-title":"Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia","volume":"86","author":"Auerbach","year":"2011","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.mayocp.2020.10.042_bib28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ajh.24361","article-title":"Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy","volume":"91","author":"Wong","year":"2016","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.mayocp.2020.10.042_bib29","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.amjmed.2017.06.025","article-title":"Results of the first American prospective study of intravenous iron in oral iron-intolerant iron-deficient gravidas","volume":"130","author":"Auerbach","year":"2017","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2020.10.042_bib30","doi-asserted-by":"crossref","first-page":"e94217","DOI":"10.1371\/journal.pone.0094217","article-title":"Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women \u2014 PREFER a randomized, placebo-controlled study","volume":"9","author":"Favrat","year":"2014","journal-title":"Plos One"},{"issue":"4","key":"10.1016\/j.mayocp.2020.10.042_bib31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2215\/CJN.05320513","article-title":"A\u00a0randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD","volume":"9","author":"Macdougall","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.mayocp.2020.10.042_bib32","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ajh.23534","article-title":"Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min","volume":"88","author":"Auerbach","year":"2013","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.mayocp.2020.10.042_bib33","doi-asserted-by":"crossref","first-page":"E229","DOI":"10.1002\/ajh.25548","article-title":"Single total dose infusion of ferumoxytol (1020 mg in 30 minutes) is an improved method of administration of intravenous iron","volume":"94","author":"Karki","year":"2019","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.mayocp.2020.10.042_bib34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ajh.25060","article-title":"Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: a randomized trial","volume":"93","author":"Adkinson","year":"2018","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.mayocp.2020.10.042_bib35","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ajh.25564","article-title":"A\u00a0prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial","volume":"94","author":"Auerbach","year":"2019","journal-title":"Am J Hematol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620313768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620313768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:35:21Z","timestamp":1758418521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619620313768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0025619620313768"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.10.042","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using Reticulocyte Hemoglobin Equivalent as a Marker for Iron Deficiency and Responsiveness to Iron Therapy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}